Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zsolt Hepp

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
The Journal of Sexual Medicine|February 10, 2018
Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary HypogonadismMichael Grabner, Zsolt Hepp, Amit Raval, et al.
Inflammatory Bowel Diseases|October 27, 2020
The Impact of Intestinal Complications on Health Care Costs Among Patients With Inflammatory Bowel Disease Treated With Anti-Tumor Necrosis Factor TherapiesDavid T Rubin, Jenny Griffith, Qisu Zhang, et al.
Current Medical Research and Opinion|June 8, 2018
Adherence to thyroid hormone replacement therapy: a retrospective, claims database analysisZsolt Hepp, Kathleen Wyne, Shivaji R Manthena, et al.
Future Oncology (London, England)|August 5, 2021
Real-world outcomes in locally advanced or metastatic urothelial carcinoma following platinum and PD-1/L1 inhibitor therapyZsolt Hepp, Sonali N Shah, Shang-Ying Liang, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Qualitative Analysis of Pain in Patients With Locally Advanced or Metastatic Urothelial CarcinomaSusan Martin, Sonali N Shah, Zsolt Hepp, et al.
Neurourology and Urodynamics|April 8, 2015
Patient-reported goal achievement following onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivityEmmanuel Chartier-Kastler, Eric Rovner, Zsolt Hepp, et al.
Journal of Medical Economics|June 9, 2016
Economic impact of onabotulinumtoxinA for overactive bladder with urinary incontinence in EuropeLewis Ruff, Emma Bagshaw, Javier Aracil, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 28, 2014
Cost-effectiveness of a computerized provider order entry system in improving medication safety ambulatory careSara H Forrester, Zsolt Hepp, Joshua A Roth, et al.
Urologic Oncology|August 4, 2022
Treatment with opioids in patients with locally advanced or metastatic urothelial carcinoma and matched non-cancer controlsMatthew D Galsky, Simrun Grewal, Yutong Liu, et al.
Cephalalgia : an International Journal of Headache|August 29, 2014
Adherence to oral migraine-preventive medications among patients with chronic migraineZsolt Hepp, David W Dodick, Sepideh F Varon, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
The Journal of Sexual Medicine|February 10, 2018
Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary HypogonadismMichael Grabner, Zsolt Hepp, Amit Raval, et al.
Inflammatory Bowel Diseases|October 27, 2020
The Impact of Intestinal Complications on Health Care Costs Among Patients With Inflammatory Bowel Disease Treated With Anti-Tumor Necrosis Factor TherapiesDavid T Rubin, Jenny Griffith, Qisu Zhang, et al.
Current Medical Research and Opinion|June 8, 2018
Adherence to thyroid hormone replacement therapy: a retrospective, claims database analysisZsolt Hepp, Kathleen Wyne, Shivaji R Manthena, et al.
Future Oncology (London, England)|August 5, 2021
Real-world outcomes in locally advanced or metastatic urothelial carcinoma following platinum and PD-1/L1 inhibitor therapyZsolt Hepp, Sonali N Shah, Shang-Ying Liang, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Qualitative Analysis of Pain in Patients With Locally Advanced or Metastatic Urothelial CarcinomaSusan Martin, Sonali N Shah, Zsolt Hepp, et al.
Neurourology and Urodynamics|April 8, 2015
Patient-reported goal achievement following onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivityEmmanuel Chartier-Kastler, Eric Rovner, Zsolt Hepp, et al.
Journal of Medical Economics|June 9, 2016
Economic impact of onabotulinumtoxinA for overactive bladder with urinary incontinence in EuropeLewis Ruff, Emma Bagshaw, Javier Aracil, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 28, 2014
Cost-effectiveness of a computerized provider order entry system in improving medication safety ambulatory careSara H Forrester, Zsolt Hepp, Joshua A Roth, et al.
Urologic Oncology|August 4, 2022
Treatment with opioids in patients with locally advanced or metastatic urothelial carcinoma and matched non-cancer controlsMatthew D Galsky, Simrun Grewal, Yutong Liu, et al.
Cephalalgia : an International Journal of Headache|August 29, 2014
Adherence to oral migraine-preventive medications among patients with chronic migraineZsolt Hepp, David W Dodick, Sepideh F Varon, et al.
Pageof 4